Home
Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. This 60-minute live and virtual symposium will include expert faculty engaged in a fast-paced, interactive discussion of prescription digital therapeutics (PDTs). Topics covered will include the definition and core concepts of PDTs; current evidence in clinical trials and PDTs on the horizon; and the role of PDTs in therapy and their potential impact in psychiatric disorders. This satellite symposium held in